Actively Recruiting

All Genders
NCT03465150

Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital

Led by Nantes University Hospital · Updated on 2026-04-13

200

Participants Needed

1

Research Sites

796 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

With 24 million results associated with Google's searchon keywords "severe acne", Pr Dreno's team understand better thatthis disease, which affects many French people, is a real concern of Public Health and not a "forced evil" of the adolescent period, which will eventually resolve itself. Acne does not affect the vital prognosis, but its psychosocial impact is major and should not be underestimated. Paradoxically, despite the high prevalence of acne, few quality epidemiological studies have been published. Physicians are often helpless when faced with patients' questions. They often need a lot of explanations, especially on the factors aggravating this dermatosis, which greatly affects their quality of life. This cohort, the first of its kind in France, will determine the predictive factors of therapeutic response, endogenous and environmental factors impacting on the severity of acne assess the quality of life and psychological impact of acne patients, determine the patient's course of care and the associated costs. Pr Dreno's team will also build up a bio collection (bacteriological samples).

CONDITIONS

Official Title

Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient with acne
  • Patient (or parents/guardians for minors) who agree to participate in the cohort
  • Subjects affiliated with appropriate health insurance
Not Eligible

You will not qualify if you...

  • Dermatosis of the face other than acne
  • Refusal to participate by the minor or parent/guardian
  • Adults under a legal protection regime such as guardianship, trusteeship, or judicial safeguard

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU de Nantes

Nantes, France, 44000

Actively Recruiting

Loading map...

Research Team

B

Brigitte DRENO

CONTACT

A

Amir khammari

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here